Evidence map›Paper›PMID 35631535›Full record

ArticlePharmaceutics2022

High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Junzhi Yang, Robert D Betterton, Erica I Williams, Joshua A Stanton, Elizabeth S Reddell, Chidinma E Ogbonnaya, Emma Dorn, Thomas P Davis, Jeffrey J Lochhead, Patrick T Ronaldson

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Brain-Targeted Drug Delivery.Pharmaceutics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Junzhi YangDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Robert D BettertonDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Erica I WilliamsDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Joshua A StantonDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Elizabeth S ReddellDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Chidinma E OgbonnayaDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Emma DornDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Thomas P DavisDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Jeffrey J LochheadDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.ORCID 0000-0001-5554-4812
Patrick T RonaldsonDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0001-9877-5370
University of Arizona · US

Funding

Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Increased CNS Opioid Exposure by an Acetaminophen-Induced Blood-Brain Barrier MechanismR01DA051812 · NIDA · UNIVERSITY OF ARIZONA · PI DAVIS, THOMAS PAUL, RONALDSON, PATRICK THOMAS · 2020 to 2024
$2.8M
UA Environmental Health Transformative Research Undergrad Experience(EH TRUE)R25ES025494 · NIEHS · UNIVERSITY OF ARIZONA · PI CHEN, YIN · 2015 to 2024
$1.1M
NIDA NIH HHS R01 DA051812NIDA NIH HHS R01-DA051812NIEHS NIH HHS R25 ES025494NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

The consumption of acetaminophen (APAP) can induce neurological changes in human subjects; however, effects of APAP on blood-brain barrier (BBB) integrity are unknown. BBB changes by APAP can have profound consequences for brain delivery of co-administered drugs. To study APAP effects, female Sprague-Dawley rats (12-16 weeks old) were administered vehicle (i.e., 100% dimethyl sulfoxide (DMSO), intraperitoneally (i.p.)) or APAP (80 mg/kg or 500 mg/kg in DMSO, i.p.; equivalent to a 900 mg or 5600 mg daily dose for a 70 kg human subject). BBB permeability was measured via in situ brain perfusion using [

Indexed as

acetaminophenblood–brain barrierclaudin-5CNS drug deliveryopioidstight junction

Identifiers

PMID35631535
PMCPMC9144323
OpenAlexW4224996505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.